Pegcetacoplan Beneficial for C3 Glomerulopathy, Immune

WEDNESDAY, Dec. 10, 2025 (HealthDay News) -- Among patients with C3 glomerulopathy or primary immune-complex membranoproliferative glomerulonephritis (MPGN), pe

See Full Page

Interests (0)

Settings

Pegcetacoplan Beneficial for C3 Glomerulopathy, Immune

Doughy Chocolate Chip Cookie packages pulled over salmonella concerns

The Senate is set to vote on two rival health plans. Here's what's at stake for Americans

Alarm as Trump admits to 3 cognitive tests monitored by room of doctors in late

Botulism outbreak sickens more than 50 babies and expands to all ByHeart products

How a rare drug made from scientists' blood saves babies from botulism

I hate getting Pap smears. Is there a safe alternative?

Clancy: Cassidy offers new path on Affordable Care Act costs

Shreveport neurosurgeon performs first-ever awake dual approach spinal fusion surgery

FDA panel calls to loosen restrictions on testosterone replacement therapy

Trump Admits Using 'Shithole' Then Continues Racist Onslaught On Somalia

Medical Imaging Contributing To Water Pollution, Experts Say

FDA Looks Into Reports of Deaths After COVID Vaccination

Leukemia Strikes Black Patients Earlier, With Higher Risk Of Death, Study Says

How Social Security beneficiaries' tax bills may change this year

Gorilla Dancing in a Forest Wins Comedy Wildlife Photo Awards 2025

Multiple injured in shooting at Kentucky State University, officials say

Here are the five big takeaways from Wednesday's Fed rate decision

Teen football players arrested after alleged $2K Dick's Sporting Goods theft

Supreme Court seems likely to back Trump's power to fire independent agency board members

Opera singer stabbed to death in home, son to be booked for homicide: Police

Trump admin moves to end major student loan forgiveness plan: 'We won't tolerate it'

The Exiled Pop Star Who Unites Iran

1 dead, 1 injured in shooting at Kentucky State University, suspect in custody: Police